Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Baxalta Sues Chugai over Hemophilia A Drug Patent
May 12, 2016
- Ono Delivers Record Sales on Buoyant Opdivo, FY2016 Outlook Tops 250 Billion Yen
May 12, 2016
- Astellas Logs Record Earnings on Bullish Xtandi in FY2015
May 12, 2016
- Entyvio on Track to Rake in US$2 Billion in FY2018, Ninlaro Eyed as Next Big Seller
May 11, 2016
- Takeda Drops Diabetic Nephropathy Drug amid Change in R&D Strategy
May 11, 2016
- Takeda Enjoys Higher Revenues and Profits as Entyvio Sales Triple
May 11, 2016
- Meiji Seika Pharma Jettisons BPH Treatment
May 11, 2016
- AZ Set to Double Japan Sales by 2020 on Cancer Meds, No Patent Cliff in Sight: Local Pres. Baertschi
May 11, 2016
- Taiho Establishes Venture Capital Unit in US to Invest in Field of Oncology
May 11, 2016
- Daiichi Sankyo Enters License Agreement with UK Company for Cell Therapy
May 11, 2016
- Aspen Japan Files Requests for Reimbursement Listing of Paxil, Valtrex AGs
May 10, 2016
- Takeda Gets US$38 Million Grant from Gates Foundation for Polio Vaccine Development
May 10, 2016
- Thorsten Poehl Takes Helm of Boehringer Japan
May 10, 2016
- D. Western Therapeutics Acquires Exclusive License to Corneal Endothelial Therapeutics from Doshisha Univ.
May 10, 2016
- Transfer of Vaccine, Blood Biz under Negotiation, All Directors to Exit in June: Kaketsuken
May 9, 2016
- Ex-Ranbaxy Shareholders Ordered to Pay 56 Billion Yen to Daiichi Sankyo
May 9, 2016
- Shingo Iwamoto to Lead Aspen Japan
May 9, 2016
- Halaven Approved for Advanced Liposarcoma in Europe: Eisai
May 9, 2016
- Brintellix Renamed Trintellix to Curb Name Confusion in US
May 9, 2016
- Ono Ups FY2015 Earnings Forecast on Brisk Opdivo Sales
May 9, 2016
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…